PATH vs YCBD · P/E 19, rev $1.61B vs P/E 0.3, rev $19.5M
Uipath Inc (PATH) versus cbdMD Inc (YCBD) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
cbdMD Inc (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported YCBD revenue for 2024-09-30 was $19.5M. Net income was -$152.8K. Revenue was down 19.3% from 2023-09-30 to 2024-09-30. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
Not investment advice. Open the PATH and YCBD stock pages for the full models.
Not investment advice.